Skip to content

Ayurvedic Management of Bronchial Asthma-A Clinical Study

â??An open-label,randomized, comparative, parallel group clinical study to evaluate the efficacy of paushkaradi kashaya and amruthadi kashaya in tamaka swasa w.s.r to bronchial asthmaâ??

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/09/027878
Enrollment
30
Registered
2020-09-17
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J459- Other and unspecified asthma

Interventions

Intervention1: Amruthadi kashaya: Ingredients :Amrutha,Nagara,Bharngi,Kantakari,Tulsi Anupana :Pippali choorna 3 grams Dose:50 ml Twice daily Duration:30 days Control Intervention1: Paushkaradi ka

Sponsors

Dr Abhijith N
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Subject with classical signs & symptoms of Tamaka swasa w.s.r to Bronchial Asthma. 2.Diagnosed cases of Bronchial Asthma 3.Subjects who are willing to participate in the study. 4.Subjects who were ready to give informed consent for the research study

Exclusion criteria

Exclusion criteria: 1.Subject suffering from COPD, TB, ILD, Pneumonia, Pulmonary embolism like complicated respiratory conditions. 2.Emergency conditions like Status asthmatics, acute chest infections, cardiac asthma, and acute respiratory distress syndrome. 3.Subject suffering from any systemic diseases like cardio vascular disorders, chronic kidney disease, carcinoma, cerebrovascular diseases, and chronic autoimmune diseases. 4.Pregnant and lactating women. 5.Psychiatric patients. 6.Diseases which interfere with the course of disease and treatment will be excluded.

Design outcomes

Primary

MeasureTime frame
Relief in clinical symptomsTimepoint: Assessment will be done on 0th day,15th day, 30th day Follow up will be done on 45th day

Secondary

MeasureTime frame
Increase in Peak expiratory flow rateTimepoint: 15th,30th and 45th day

Countries

India

Contacts

Public ContactDr Sowmyashree U P

Sri Sri College of Ayurvedic science and Research

upsprasad@gmail.com9743893056

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026